id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0157-0004,FDA,FDA-2003-N-0157,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Submitting and Reviewing Complete Responses to Clinical Holds,Notice,Notice of Approval,2003-12-16T05:00:00Z,2003,12,,,2025-02-27T17:09:04Z,03-30963,0,0,0900006480487917
FDA-2003-N-0157-0003,FDA,FDA-2003-N-0157,Supporting Statement - Guidance for Industry: Submitting and Reviewing Complete Responses to Clinical Holds,Supporting & Related Material,Background Material,2003-12-16T05:00:00Z,2003,12,,,2025-02-27T17:27:11Z,,0,0,0900006480487915
FDA-2003-N-0157-0002,FDA,FDA-2003-N-0157,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry on Submitting and Reviewing Complete Responses to Clinical Holds,Notice,30 Day Proposed Information Collection,2003-07-23T04:00:00Z,2003,7,2003-07-23T04:00:00Z,2003-08-23T03:59:59Z,2025-02-27T17:06:53Z,03-18691,0,0,0900006480487912
FDA-2003-N-0157-0001,FDA,FDA-2003-N-0157,Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on Submitting and Reviewing Complete Responses to Clinical Holds,Notice,60 Day Proposed Information Collection,2003-04-21T04:00:00Z,2003,4,2003-04-21T04:00:00Z,2003-06-21T03:59:59Z,2025-02-27T16:59:38Z,03-9664,0,0,09000064804878d0